128 related articles for article (PubMed ID: 17076642)
1. Isolation, characterization and study of enhancing effects on nasal absorption of insulin in rat of the total saponin from Acanthophyllum squarrosum.
Sajadi Tabassi SA; Hosseinzadeh H; Ramezani M; Moghimipour E; Mohajeri SA
Curr Drug Deliv; 2006 Oct; 3(4):399-404. PubMed ID: 17076642
[TBL] [Abstract][Full Text] [Related]
2. DS-1, a modified Quillaja saponin, enhances ocular and nasal absorption of insulin.
Pillion DJ; Recchia J; Wang P; Marciani DJ; Kensil CR
J Pharm Sci; 1995 Nov; 84(11):1276-9. PubMed ID: 8587042
[TBL] [Abstract][Full Text] [Related]
3. Nasal delivery of insulin using bioadhesive chitosan gels.
Varshosaz J; Sadrai H; Heidari A
Drug Deliv; 2006; 13(1):31-8. PubMed ID: 16401591
[TBL] [Abstract][Full Text] [Related]
4. Mutual inhibition of the insulin absorption-enhancing properties of dodecylmaltoside and dimethyl-beta-cyclodextrin following nasal administration.
Ahsan F; Arnold JJ; Meezan E; Pillion DJ
Pharm Res; 2001 May; 18(5):608-14. PubMed ID: 11465415
[TBL] [Abstract][Full Text] [Related]
5. Aminated gelatin as a nasal absorption enhancer for peptide drugs: evaluation of absorption enhancing effect and nasal mucosa perturbation in rats.
Wang J; Sakai S; Deguchi Y; Bi D; Tabata Y; Morimoto K
J Pharm Pharmacol; 2002 Feb; 54(2):181-8. PubMed ID: 11848281
[TBL] [Abstract][Full Text] [Related]
6. Nasal absorption and local tissue reaction of insulin nanocomplexes of trimethyl chitosan derivatives in rats.
Jintapattanakit A; Peungvicha P; Sailasuta A; Kissel T; Junyaprasert VB
J Pharm Pharmacol; 2010 May; 62(5):583-91. PubMed ID: 20609059
[TBL] [Abstract][Full Text] [Related]
7. Structure-function relationship among Quillaja saponins serving as excipients for nasal and ocular delivery of insulin.
Pillion DJ; Amsden JA; Kensil CR; Recchia J
J Pharm Sci; 1996 May; 85(5):518-24. PubMed ID: 8742944
[TBL] [Abstract][Full Text] [Related]
8. Delivery of systemic regular insulin via the ocular route in cats.
Morgan RV
J Ocul Pharmacol Ther; 1995; 11(4):565-73. PubMed ID: 8574820
[TBL] [Abstract][Full Text] [Related]
9. Systemic absorption of insulin and glucagon applied topically to the eyes of rats and a diabetic dog.
Pillion DJ; Wang P; Yorks J; McCann P; Meezan E
J Ocul Pharmacol Ther; 1995; 11(3):283-95. PubMed ID: 8590261
[TBL] [Abstract][Full Text] [Related]
10. On employing a translationally controlled tumor protein-derived protein transduction domain analog for transmucosal delivery of drugs.
Bae HD; Lee K
J Control Release; 2013 Sep; 170(3):358-64. PubMed ID: 23791976
[TBL] [Abstract][Full Text] [Related]
11. Nasal absorption enhancement of insulin by sodium deoxycholate in combination with cyclodextrins.
Zhang Y; Jiang XG; Yao J
Acta Pharmacol Sin; 2001 Nov; 22(11):1051-6. PubMed ID: 11749800
[TBL] [Abstract][Full Text] [Related]
12. Screening of cationic compounds as an absorption enhancer for nasal drug delivery.
Natsume H; Iwata S; Ohtake K; Miyamoto M; Yamaguchi M; Hosoya K; Kobayashi D; Sugibayashi K; Morimoto Y
Int J Pharm; 1999 Aug; 185(1):1-12. PubMed ID: 10425360
[TBL] [Abstract][Full Text] [Related]
13. Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation.
Zaki NM; Mortada ND; Awad GA; Abd ElHady SS
Int J Pharm; 2006 Dec; 327(1-2):97-103. PubMed ID: 16959453
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of nasal absorption of insulin using chitosan nanoparticles.
Fernández-Urrusuno R; Calvo P; Remuñán-López C; Vila-Jato JL; Alonso MJ
Pharm Res; 1999 Oct; 16(10):1576-81. PubMed ID: 10554100
[TBL] [Abstract][Full Text] [Related]
15. One-month subchronic toxicity study of cell-penetrating peptides for insulin nasal delivery in rats.
Khafagy el-S; Kamei N; Nielsen EJ; Nishio R; Takeda-Morishita M
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):736-43. PubMed ID: 24060698
[TBL] [Abstract][Full Text] [Related]
16. Enhancing effect of cyclodextrins on nasal absorption of insulin and its duration in rabbits.
Watanabe Y; Matsumoto Y; Kawamoto K; Yazawa S; Matsumoto M
Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3100-4. PubMed ID: 1477928
[TBL] [Abstract][Full Text] [Related]
17. Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of in vitro release and in vivo insulin absorption in rats.
Wang J; Tabata Y; Morimoto K
J Control Release; 2006 Jun; 113(1):31-7. PubMed ID: 16707188
[TBL] [Abstract][Full Text] [Related]
18. Bile salt-fatty acid mixed micelles as nasal absorption promoters of peptides. II. In vivo nasal absorption of insulin in rats and effects of mixed micelles on the morphological integrity of the nasal mucosa.
Tengamnuay P; Mitra AK
Pharm Res; 1990 Apr; 7(4):370-5. PubMed ID: 2194199
[TBL] [Abstract][Full Text] [Related]
19. Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies.
Sintov AC; Levy HV; Botner S
J Control Release; 2010 Dec; 148(2):168-76. PubMed ID: 20709120
[TBL] [Abstract][Full Text] [Related]
20. The enhancing effect of soybean-derived sterylglucoside and beta-sitosterol beta-D-glucoside on nasal absorption in rabbits.
Maitani Y; Nakamura K; Suenaga H; Kamata K; Takayama K; Nagai T
Int J Pharm; 2000 Apr; 200(1):17-26. PubMed ID: 10845682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
